Literature
首页医源资料库在线期刊美国临床营养学杂志2003年77卷第4期

Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritoneal dial

来源:《美国临床营养学杂志》
摘要:ABSTRACTBackground:Anorexiathatresultsininadequatenutrientintakeisconsideredoneofthemostimportantcausesofmalnutritionindialysispatients。Objective:Theobjectivewastodeterminefactorsotherthandialysisadequacythatareassociatedwithinadequateproteinandenergyintak......

点击显示 收起

Angela Yee-Moon Wang, John Sanderson, Mandy Man-Mei Sea, Mei Wang, Christopher Wai-Kei Lam, Philip Kam-Tao Li, Siu-Fai Lui and Jean Woo

1 From the Department of Medicine and Therapeutics (AY-MW, JS, MW, PK-TL, and S-FL), the Center for Nutritional Studies (MM-S and JW), and the Department of Chemical Pathology (CW-KL), Prince of Wales Hospital, Chinese University of Hong Kong, New Territories.

2 Supported by the Bristol Myers Squibb Foundation Unrestricted Nutrition Grant Program, of which JW was the Principal Investigator.

3 Address reprint requests to AY-M Wang, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. E-mail: awang{at}cuhk.edu.hk.


ABSTRACT  
Background: Anorexia that results in inadequate nutrient intake is considered one of the most important causes of malnutrition in dialysis patients.

Objective: The objective was to determine factors other than dialysis adequacy that are associated with inadequate protein and energy intakes in patients receiving continuous ambulatory peritoneal dialysis.

Design: Dietary protein and energy intakes were assessed with a food-frequency questionnaire in 266 patients, and factors other than dialysis adequacy that are potentially associated with reductions in energy and protein intakes were examined.

Results: Only 39% of the patients had protein intakes 1.2 g • kg- 1 • d- 1, and 26% had energy intakes 126 kJ • kg- 1 • d- 1. Other than having a greater total urea clearance and glomerular filtration rate, patients with protein intakes 1.2, as opposed to < 1.2, g • kg- 1 • d- 1 had lower high-sensitive C-reactive protein concentrations and fewer complications with volume overload (29% compared with 46%; P = 0.006). Patients with energy intakes 126, as opposed to < 126, kJ • kg- 1 • d- 1 were younger, had lower high-sensitive C-reactive protein concentrations, and had a lower prevalence of diabetes (P = 0.006), atherosclerotic vascular disease (P = 0.020), and history of volume overload (P = 0.013). Multiple regression analysis showed that other than increasing age, diabetes, and total urea clearance, having a history of volume overload was independently associated with a 0.22-g • kg- 1 • d- 1decrease in protein (P = 0.001) and a 13.07-kJ • kg- 1 • d- 1 decrease in energy intake (P = 0.006).

Conclusion: An important yet unrecognized association was observed between a history of volume overload and dietary intake in peritoneal dialysis patients.

Key Words: Protein intake • energy intake • volume overload • malnutrition • anorexia • continuous ambulatory peritoneal dialysis


INTRODUCTION  
Protein-energy malnutrition is a powerful predictor of morbidity and mortality in dialysis patients (1–3). Its prevalence has been reported to vary from 23% to 76% in hemodialysis patients and from 18% to 56% in patients receiving continuous ambulatory peritoneal dialysis (CAPD) (4–8). Numerous factors contribute to malnutrition in the dialysis population, among which inadequate nutrient intake is regarded to be one of the most important (9, 10). Although hemodialysis and CAPD patients are recommended to have a daily protein intake of 1.2 g/kg and an energy intake of 146 kJ/kg body wt (9, 11, 12), nutritional surveys indicate that actual protein and energy intakes are inadequate in most patients receiving maintenance dialysis (13–16). CAPD patients have even more inadequate intakes than do hemodialysis patients (16).

Many factors are responsible for inadequate nutrient intakes in dialysis patients, among which anorexia has been implicated to be one of the most important. Anorexia may be the result of uremic toxin accumulation, underlying illnesses such as diabetes mellitus with impaired gastric emptying, comorbidity, and acute superimposed illnesses such as peritonitis and infections. Persistent uremia due to inadequate dialysis is considered by far the most important anorectic factor for dialysis patients (17). Intraperitoneal injection of uremic toxins with a molecular mass between 1.0 and 1.5 kDa into normal rats suppresses appetite and food intake in a dose-related fashion (18). The CANADA-USA study showed an improvement of appetite with initiation of dialysis in patients with renal failure (19). Our recent study, which showed the significant cross-section relation between the degree of residual renal function as well as total urea clearance and actual protein and energy intakes in CAPD patients (20), provides further evidence that dietary intake is indeed associated with the degree of urea clearance. However, the importance of other clinical factors remains largely undetermined.

This study examined the actual protein and energy intakes among local Chinese CAPD patients and evaluated the importance of the different clinical factors, particularly the presence of comorbidity in relation to dietary intake. Volume overload is a frequent complication in dialysis patients. However, its relation with the actual intakes of dialysis patients has never been evaluated.


SUBJECTS AND METHODS  
Study population
The study population consisted of all prevalent patients (n = 266) receiving maintenance CAPD for 3 mo in the Prince of Wales Hospital in Hong Kong, except for those with underlying malignancy, those with ongoing systemic inflammatory disease (eg, systemic lupus erythematosus), those with active tuberculosis and still receiving treatment, and those who refused to participate. Informed consent was obtained from all patients. The study protocol was approved by the Human Research Ethics Committee, Chinese University of Hong Kong.

Dietary assessment
All patients completed a 7-d food-frequency questionnaire that was well validated in the Chinese population (21, 22) to estimate the average daily protein and energy intakes. The food-frequency questionnaire was performed by experienced research staff blinded to all clinical and biochemical details of the patients. Estimated protein and energy intakes were normalized to the patients’ actual dry body weights, as measured with a weighing scale, after the abdomen had been drained dry of peritoneal fluid. In patients who developed acute intercurrent illness such as infections or peritonitis, dietary assessment was deferred for 1 mo after resolution of the acute event. Patients were categorized into those with dietary protein intakes 1.2 or < 1.2 g • kg- 1 • d- 1 and those with energy intakes 126 or < 126 kJ • kg- 1 • d- 1.

Indexes of dialysis adequacy
Adequacy of dialysis was determined by measuring total weekly urea clearance and creatinine clearance with the use of standard methods (23). The contribution of urea clearance by peritoneal dialysis (PD urea clearance) and residual renal function was estimated separately. Residual glomerular filtration rate (GFR) was calculated as an average of the 24-h urinary urea and creatinine clearances (24). Creatinine concentration in dialysate was corrected for interference by glucose according to the reference formula determined in our laboratory (25). Total body water was derived by using Watson’s formula (26).

Data collection
Information regarding the cause of renal failure, duration of dialysis, smoking history, use of erythropoietin, exit site infection and peritonitis within 6 mo before dietary assessment, and history of diabetes, atherosclerotic vascular disease (AVD), and episodes of volume overload was retrieved from case records and hospitalization records. A single experienced physician further interviewed all patients to confirm the presence of AVD and history of volume overload.

AVD was defined as the presence of any atherosclerotic complication, including ischemic heart disease, with a history of angina, previous myocardial infarction, coronary artery bypass surgery or stenting, cerebrovascular disease, transient ischemic attack, or peripheral vascular disease with or without amputation.

A history of volume overload was defined clinically as the occurrence of one or more episodes of volume overload at any time point between the time of dialysis initiation and the time of dietary assessment. Volume overload was defined as the presence of symptoms and signs of heart failure, such as dyspnea, elevated jugular venous pressure, and basal crepitations together with pulmonary venous congestion or interstitial edema on chest radiograph (27). Radiographic evidence of pulmonary congestion or interstitial edema is an essential criterion for the diagnosis of volume overload and was further confirmed by resolution of symptoms, signs, and radiographic changes with hypertonic PD exchanges.

Echocardiography
Echocardiography was performed with a GE-VingMed System V echocardiographic machine (Horten, Norway) and a 3.5-mHz multiphase-array probe by an experienced cardiologist blinded to all clinical details of the patients. The echocardiographic techniques and calculations of different cardiac dimensions were performed according to recommendations of the American Society of Echocardiography (28, 29). Left ventricular hypertrophy was defined as a left ventricular mass index 131 g/m2 in men and 100 g/m2 in women, in accordance with the Framingham criteria (30). Systolic dysfunction was defined as those with an ejection fraction (EF) < 45%, whereas diastolic dysfunction was defined according to the guidelines published by the European Study Group on Diastolic Heart Failure (31) with 4 different patterns of diastolic function: normal, impaired relaxation, pseudonormal, and restrictive filling pattern (32).

Biochemical factors
At the time of the dietary assessment, patients had simultaneous venous blood samples taken to determine high-sensitive C-reactive protein (hsCRP), bicarbonate, hemoglobin, calcium, phosphate, and parathyroid hormone concentrations. hsCRP was measured with the use of the Tina-quant CRP (Latex) ultrasensitive assay (Roche Diagnostics GmbH, Mannheim, Germany). A concentration > 2 mg/L is considered to be elevated. Parathyroid hormone was measured with an Immulite immunoassay (Diagnostic Products Corporation, Los Angeles).

Statistical analysis
Statistical analysis was performed with the use of SPSS software (version 10.0; SPSS, Inc, Chicago). Continuous variables were expressed as means ± SDs or medians (interquartile ranges), whereas categorical variables were reported as the number and percentage of subjects. Continuous variables were compared by using Student’s t test or the Mann-Whitney U test, where appropriate, whereas categorical variables were compared by using chi-square tests. Dietary protein and energy intakes were then entered into the multiple linear regression model as continuous dependent variables; factors with a P value < 0.25 in univariate analysis were selected into the multivariate regression model. A backward stepwise elimination procedure with a P value > 0.05 to remove was performed to identify factors significantly associated with inadequate dietary protein and energy intakes in CAPD patients. All P values were two-tailed, and a P value < 0.05 was considered significant.


RESULTS  
The clinical characteristics of the patients are shown in Table 1. Fifty-eight patients had AVD (22%), whereas 104 (39%) patients had a history of volume overload. The daily PD exchange volume was 6.7 ± 1.3 L. Dietary protein and energy intakes were 1.11 ± 0.45 g • kg- 1 • d- 1 and 105 ± 38 kJ • kg- 1 • d- 1, respectively. The addition of peritoneal glucose energy ( ± SD: 17 ± 8 kJ • kg- 1 • d- 1) increased total energy input to 121 ± 38 kJ • kg- 1 • d- 1 and remained below that recommended for CAPD patients. Only 104 (39%) patients achieved protein intakes 1.2 g • kg- 1 • d- 1. Protein intakes were between 1 and 1.2 g • kg- 1 • d- 1 in 44 (17%) patients and < 1 g • kg- 1 • d- 1 in 118 (44%) patients. Energy intakes were even more deficient: < 126 kJ • kg- 1 • d- 1 and between 126 and 146 kJ • kg- 1 • d- 1 in 198 (75%) and 30 (11%) patients, respectively. Even with the addition of peritoneal glucose energy, only 52 (20%) patients achieved the recommended energy input of 146 kJ • kg- 1 • d- 1. This is in contrast with data from our previous 1995 Adult Dietary Survey in 1010 (500 men and 510 women) control subjects with a mean (± SD) age of 46 ± 12 y (21,
View this table:
TABLE 1 . Characteristics of the study patients  
Patients with protein intakes 1.2 g • kg- 1 • d- 1 (n = 104) were compared with those with intakes < 1.2 g • kg- 1 • d- 1 (n = 162) (Table 2). Patients with protein intakes 1.2 g • kg- 1 • d- 1 were younger and had a significantly greater prevalence of chronic glomerulonephritis but a lower prevalence of diabetic nephropathy and hypertensive nephrosclerosis as the cause of renal failure. A trend toward more diabetics and a higher prevalence of AVD was noted among patients with the lower protein intake, although the trend was not significant. Forty-six percent of patients with protein intakes < 1.2 g • kg- 1 • d- 1 had a history of volume overload compared with 29% of those with intakes 1.2 g • kg- 1 • d- 1 (P = 0.006). The incidences of exit site infection, peritonitis, and hospitalization were not significantly different between the 2 groups. hsCRP was significantly higher in patients with inadequate protein intakes than in those with protein intakes 1.2 g • kg- 1 • d- 1. Patients with the lower protein intakes were significantly more anemic, yet no significant difference was noted in the use of erythropoietin between the 2 groups. Patients with protein intakes 1.2 g • kg- 1 • d- 1 had significantly higher residual GFRs and total urea clearance than did those with inadequate protein intakes. Yet, no difference was noted in the PD urea clearance between the 2 groups. The degree of hyperparathyroidism and acidosis did not differ significantly between the 2 groups.


View this table:
TABLE 2 . Clinical, biochemical, and dialytic variables for patients with dietary protein intakes or < 1.2 g•kg- 1•d- 1  
Patients with energy intakes 126 kJ • kg- 1 • d- 1 (n = 68) were compared with those with intakes < 126 kJ • kg- 1 • d- 1 (n = 198) (Table 3). Compared with patients with energy intakes < 126 kJ • kg- 1 d- 1, patients with energy intakes 126 kJ • kg- 1 d- 1 were significantly younger and had a higher prevalence of chronic glomerulonephritis and a lower prevalence of diabetic nephropathy and hypertensive nephrosclerosis as the cause of renal failure. They also had a lower prevalence of diabetes, AVD, and history of volume overload. Patients with energy intakes < 126 kJ • kg- 1 • d- 1 had a significantly higher hsCRP concentration and were more anemic despite a similar use of erythropoietin. Residual GFR, renal urea clearance, and resulting total urea clearance were significantly higher in patients with energy intakes 126 kJ • kg- 1 • d- 1 than in those with intakes < 126 kJ • kg- 1 • d- 1, despite no significant difference in PD urea clearance.


View this table:
TABLE 3 . Clinical, biochemical, and dialytic variables for patients with dietary energy intakes or < 126 kJ•kg- 1•d- 1  
Multiple regression analysis showed that every 1-y increase in age was associated with a 0.15-g • kg- 1 • d- 1 decrease (95% CI: -0.01, -0.001 g • kg- 1 • d- 1; P = 0.020) in protein intake and a 0.64-kJ • kg- 1 d- 1 decrease (95% CI: -1.02, -0.26 kJ • kg- 1 • d- 1; P = 0.002) in energy intake. The presence of diabetes was associated with a 15.60-kJ • kg- 1 • d- 1 decrease in energy intake (95% CI: -25.65, -5.54 kJ • kg- 1 d- 1; P = 0.003). Every 0.25-unit increase in the total weekly urea clearance was associated with a 0.05-g • kg- 1 d- 1 increase in protein intake (95% CI: 0.02, 0.08 g • kg- 1 • d- 1; P = 0.002) and a 2.39-kJ • kg- 1 d- 1 increase in energy intake (95% CI: 0.06, 4.85 kJ • kg- 1 • d- 1; P = 0.056). A history of volume overload was independently associated with a 0.22-g • kg- 1 d- 1 decrease in protein intake (95% CI: -0.32, -0.09 g • kg- 1 • d- 1; P = 0.001) and a 13.07-kJ • kg- 1 d- 1 decrease in energy intake (95% CI: -22.43, -3.72 kJ • kg- 1 • d- 1; P = 0.006) (Table 4). The lower the dietary protein (P = 0.001) and energy (P = 0.001) intakes, the greater was the prevalence of a history of volume overload (Figure 1).


View this table:
TABLE 4 . Multiple regression analysis showing important factors associated with dietary protein and energy intakes in patients receiving continuous ambulatory peritoneal dialysis  

View larger version (16K):
FIGURE 1. . Prevalence of a history () or no history () of volume overload in relation to daily dietary protein and energy intakes in patients receiving continuous ambulatory peritoneal dialysis. As protein and energy intakes increased, the percentage of patients with a history of volume overload decreased (P < 0.01).

 
Echocardiographic variables of patients with or without a history of volume overload are shown in Table 5. Sixteen patients did not report for the echocardiographic examinations; therefore, results were available for only 250 patients. Patients with a history of volume overload had a significantly greater left ventricular mass index, left ventricular posterior wall thickening, and left ventricular end-diastolic diameter; a lower left ventricular EF and fractional shortening; and a higher prevalence of systolic dysfunction as defined by an EF < 45%. Moreover, a significantly greater prevalence of restrictive diastolic filling pattern was observed in patients with a history of volume overload (P = 0.001).


View this table:
TABLE 5 . Echocardiographic variables for patients with or without a history of volume overload1  

DISCUSSION  
Inadequate dietary intake is considered the single most important cause of malnutrition in dialysis patients and is largely attributed to uremia secondary to inadequate dialysis (17). The importance of clinical factors other than dialysis adequacy has never been evaluated. This study is the first to show an important association between cardiac comorbidity, particularly a history of volume overload, and dietary protein and energy intakes in CAPD patients. Our results are contrary to the current belief that anorexia in dialysis patients is most commonly the result of uremia secondary to inadequate dialysis (17). We hypothesized that the hyperosmolality associated with the use of hypertonic exchanges and high fill volume of peritoneal fluid may exert an inhibitory effect on food consumption (33). Inadequate intakes in patients with a history of volume overload may also be partly related to elevated concentrations of tumor necrosis factor (TNF) or other proinflammatory cytokines (34). Elevated TNF concentrations are associated with anorexia and malnutrition in PD patients (35) and with chronic heart failure (36). A study by Anker et al (37) showed peripheral loss of muscle mass in chronic heart failure to be associated with elevated TNF and interleukin 6 concentrations. The chronic inflammatory state is suggested to be the result of bacterial or endotoxin translocation due to bowel wall edema after severe heart failure (38). TNF and interleukin 1 induced anorexia and cachexia by inhibiting the normal adaptive feeding response to energy deficits. They augmented leptin synthesis and release despite the decrease in food intake that would normally suppress leptin expression (39, 40), indicating that hyperleptinemia may be responsible, in part, for preventing the normal compensatory mechanisms in the face of decreased food intake. On the other hand, hyperproduction of intracerebral serotonin secondary to high concentrations of TNF and IL-1 may also be involved in appetite suppression in dialysis patients (41, 42). The significantly higher hsCRP concentrations among patients with the lower protein and energy intakes indicate that inflammation may have a role in appetite suppression, although the exact proinflammatory cytokine and the mechanisms involved require elucidation. On the other hand, higher hsCRP concentrations among the patients with inadequate dietary intakes, indicating a greater degree of inflammation, may also be a marker of the presence of underlying cardiac comorbidity.

Dietary intake was deliberately not assessed at the time of volume overload but rather some time after the resolution of volume overload. Dietary intake continued to be inadequate long after resolution of volume overload. This suggested that either the episode of volume overload induced a persistent appetite-suppressive effect or that these patients remained in subclinical volume overload status. It is, however, important to caution that because of the cross-sectional design of the study and because of the retrospective diagnosis of volume overload, we were unable to assign a cause and effect relation between volume overload, inflammation, and dietary intake. Further prospective longitudinal study is needed to clarify the exact interrelations between volume overload, proinflammatory cytokines, and appetite suppression in dialysis patients.

The term volume overload encompasses not only episodes due to extracellular fluid overload but also episodes due to true cardiac dysfunction, because in practical terms it is very difficult to distinguish the 2 entities in dialysis patients. Although patients with a history of volume overload had more severe left ventricular hypertrophy and left ventricular dilatation as well as a lower EF, only 8% had systolic dysfunction as defined by an EF < 45%, whereas 80% had diastolic dysfunction. This is in keeping with the results of a recent study in which EF was not low in patients with hypertensive pulmonary edema and that pulmonary edema occurred as a result of exacerbation of diastolic but not of systolic dysfunction (43). The greater prevalence of restrictive filling pattern indeed indicated more severe diastolic dysfunction among those patients with a history of volume overload (44). On the other hand, 90% of the patients with a history of volume overload had normal systolic function, whereas 20% had normal diastolic function. These findings suggest that volume overload also occurred as a result of poor ultrafiltration or fluid noncompliance without ventricular dysfunction.

Although the CAPD patients were recommended to have protein intakes 1.2 g • kg- 1 • d- 1 and energy intakes 146 kJ • kg- 1 • d- 1 (11), up to 60% of our patients failed to reach the target protein intake. Energy intake was even more inadequate; only 14% of our patients had energy intakes 146 kJ • kg- 1 • d- 1. Even with additional energy from peritoneal glucose absorption, the total energy input remained < 146 kJ • kg- 1 • d- 1 in 80% of the patients. Of more concern was the considerably lower energy intake than protein intake. This phenomenon was also observed in other surveys, which showed an average protein intake of 1 g • kg- 1 d- 1 and an average energy intake of 96–100 kJ • kg- 1 • d- 1 in CAPD patients (45–47). Studies suggest that the intake of carbohydrates was suppressed in these patients because of an adaptive mechanism in response to obligatory peritoneal glucose absorption (48). Whether this explains the markedly lower energy than protein intake requires further evaluation. In the current study, 126 kJ • kg- 1 • d- 1 was used as the minimum daily energy requirement instead of 146 kJ • kg- 1 • d- 1 because peritoneal glucose energy (average: 17 kJ • kg- 1 • d- 1) had not yet been taken into account.

Persistent uremia due to inadequate dialysis is considered to be one of the most important anorectic factors in dialysis patients (49). Spontaneous reduction in protein intake was noted with progression of renal failure, indicating that decreased clearance of uremic substances was associated with progressive anorexia at all stages of renal failure (50). Our results showed that total urea clearance and residual GFR, but not PD urea clearance, were associated with protein and energy intakes in CAPD patients. The CANADA-USA study showed that low urea clearance was associated with low protein intake (19). Although higher protein intakes and a better nutrition status were observed among patients with higher weekly urea clearance (20, 51), the prospective analysis by Harty et al (51) showed that the dependence of protein intake on urea clearance was mainly in those patients with a reduction in clearance due to loss of residual renal function. An increase in the PD urea clearance to offset such losses was not accompanied by improvements in protein intake. This was consistent with our recent findings (20) that PD and renal urea clearance are not equivalent in terms of their solute removal and that residual renal function had a significant contribution to the overall urea clearance and nutrition status of PD patients (52).

Comorbid factors—including advanced age, diabetes, and AVD—were predictive of higher mortality (53) and increased risk of malnutrition in dialysis patients (5). Our current study showed that age was an important factor associated with inadequate protein and energy intakes. More patients with diabetic or hypertensive nephropathy had inadequate protein and energy intakes, which may have been related to the higher prevalence of cardiac comorbidity in these patients. The presence of diabetes was significantly associated with an inadequate energy but not protein intake. Low energy intakes in diabetic patients indicate that either these patients have an incorrect perception of their daily energy intake allowance and have been brainwashed to have a lower energy intake or that they experience more anorectic symptoms and hence have a poorer intake. Patients with AVD had significantly lower energy intakes and a trend toward lower protein intakes than did those with no AVD. The degree of metabolic acidosis and hyperparathyroidism showed no significant relation with protein or energy intake. This finding indicates that these conditions increased malnutrition by promoting protein catabolism, as suggested by other studies (54, 55), rather than inducing a direct appetite-suppressive effect.

In summary, intakes of protein and energy were inadequate in most of the CAPD patients. Other than showing an association between dietary intakes and total urea clearance, residual renal function, increasing age, and diabetes was observed, we showed an important yet unrecognized association between inadequate protein and energy intakes and a history of volume overload in CAPD patients. The appetite-suppressive effect for protein and energy intakes persists long after resolution of the episode of volume overload. Our data suggest that preventing volume overload may be important in ensuring adequate dietary intakes of protein and energy and in preventing malnutrition in peritoneal dialysis patients. The exact mechanisms underlying the association between volume overload and persistent anorexia in dialysis patients require further elucidation.


ACKNOWLEDGMENTS  
We acknowledge the valuable assistance of Man-Ching Law in retrieving clinical data and of Ly-Mee Yu (Centre for Clinical Trials and Epidemiologic Research, Chinese University of Hong Kong) in providing statistical support for the study.

AY-MW contributed to the concept of the study, study design, data collection, data analysis, and writing of the manuscript. JS contributed to the study design, data collection, and review of the manuscript. MM-MS, MW, and CW-KL contributed to the data collection. PK-TL and S-FL contributed to the study design and review of the manuscript. JW contributed to the idea of the study, study design, and review of the manuscript. None of the contributing authors had any financial or personal interest in any company or organization sponsoring the research.


REFERENCES  

  1. Acchiardo SR, Moore LW, Latour PA. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983;24:S199–203.
  2. Teehan BP, Schleifer CR, Brown JM, et al. Urea kinetic analysis and clinical outcome on CAPD. A five-year longitudinal study. Adv Perit Dial 1990;6:181–5.
  3. Davies SJ, Russell L, Bryan J, et al. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis: their interrelationship and prediction of survival. Am J Kidney Dis 1995;26:353–61.
  4. Bergstrom J, Lindholm B. Nutrition and adequacy of dialysis: how do hemodialysis and CAPD compare? Kidney Int 1993;43:S39–50.
  5. Qureshi AR, Alvestrand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998;53:773–82.
  6. Cianciaruso B, Brunori G, Kopple JD, et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1998;26:475–86.
  7. Young GA, Kopple JD, Lindholm B, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991;17:462–71.
  8. Fenton SSA, Johnston N, Delmore T, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients. ASAIO Trans 1987;33:650–3.
  9. Kluthe R, Luttgen FM, Capetianu T, et al. Protein requirements in maintenance hemodialysis. Am J Clin Nutr 1978;31:1812–20.
  10. Kopple JD, Berg R, Houser H, et al. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int 1989;36:S184–94.
  11. Kopple JD, Blumenkrantz MJ. Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1983;24:S295–302.
  12. Bergstrom J. Nutritional requirements of hemodialysis patients. In: Mitch WE, Klahr S, eds. Nutrition and the kidney. Boston: Little, Brown and Co, 1993:263–89.
  13. Jacob V, Le Carpentier JE, Salzano S, et al. IGF-1, a marker of undernutrition in hemodialysis patients. Am J Clin Nutr 1990;52:39–44.
  14. Schoenfeld P, Henry R, Laird N, Roxe D. Assessment of nutritional status of the national cooperative study population. Kidney Int 1982;23:80–8.
  15. Lindholm B, Alvestrand A, Furst P, et al. Efficacy and clinical experience of CAPD—Stockholm, Sweden. In: Atkins R, Thomson N, Farrell PC, eds. Peritoneal dialysis. Edinburgh: Churchill Livingstone, 1981:147–61.
  16. Lysaght M, Pollock C, Hallet M, et al. The relevance of urea kinetic modeling to CAPD. Trans Am Soc Artif Intern Organs 1989;35:784–90.
  17. Kopple JD. Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr 1999;129:S247–51.
  18. Bergstrom J, Mamoun H, Anderstam B, Sodersten P. Middle molecules (MM) isolated from uremic ultrafiltrate (UF) and normal urine induce dose-dependent inhibition of appetite in the rat. J Am Soc Nephrol 1994;5:488 (abstr).
  19. McCusker FX, Teehan BP, Thorpe KE, et al. For the CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. How much peritoneal dialysis is required for maintenance of a good nutritional state? Kidney Int 1996;50:S56–61.
  20. Wang AY, Sea MM, Ip R, et al. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie and other nutrients intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001;12:2450–7.
  21. Woo J, Leung SSF, Ho SC, et al. A food frequency questionnaire for use in the Chinese population in Hong Kong: description and examination of validity. Nutr Res 1997;17:1633–41.
  22. Leung SF, Woo J, Ho S, et al. Hong Kong adult dietary survey 1995. Aust J Nutr Diet 1998;55:S11–3.
  23. Nolph KD, Moore HL, Twardowski ZJ, et al. Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1992;38:M139–42.
  24. Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7:745–8.
  25. Mak TW, Cheung CK, Cheung CM, et al. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 1997;12:184–6.
  26. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27–39.
  27. Harnett JD, Foley RN, Kent GM, et al. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995;47:884–90.
  28. Sahn DJ, De Maria A, Kisslo J, Weyman A. Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072–83.
  29. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67.
  30. Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988;108:7–13.
  31. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990–1003.
  32. Cohen GI, Pietrolungo JF, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996;27:1753–60.
  33. Balaskas EV, Rodela H, Oreopoulos DG. Effect of intraperitoneal infusion of dextrose and amino acids on the appetite of rabbits. Perit Dial Int 1993;13:S490–8.
  34. Sonti G, Llyin SE, Plata-Salaman CR. Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 1996;270:R1394–402.
  35. Aguilera A, Codoceo R, Selgas R, et al. Anorexigen (TNF-, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant 1998;13:1476–83.
  36. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236–41.
  37. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526–34.
  38. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 1999;115:836–47.
  39. Sarraf P, Frederich RC, Turner EM. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185:171–5.
  40. Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutr Rev 1998;56:38–46.
  41. Aguilera A, Selgas R, Codoceo R, Bajo A. Uremic anorexia: a consequence of persistently high brain serotonin levels? The tryptophan/serotonin disorder hypothesis. Perit Dial Int 2000;20:810–6.
  42. Langhans W, Hrupka B. Interleukins and tumour necrosis factor as inhibitors of food intake. Neuropeptides 1999;33:415–24.
  43. Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344:17–22.
  44. Yu CM, Sanderson JE, Shum IO, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996;17:1694–702.
  45. Guarnieri G, Toigo G, Situlin R, et al. Muscle biopsy studies in chronically uremic patients: evidence for malnutrition. Kidney Int 1983;24:S187–93.
  46. Schilling H, Wu G, Pettit J, et al. Nutritional status of patients on long-term CAPD. Perit Dial Bull 1985;5:12–8.
  47. Pollock CA, Allen BJ, Warden RA, et al. Total body nitrogen by neutron activation analysis in maintenance dialysis. Am J Kidney Dis 1990;16:38–45.
  48. Baeyer HV, Gahl GM, Riedinger H, et al. Adaptation of CAPD patients to the continuous peritoneal energy uptake. Kidney Int 1983;23:29–34.
  49. Lindholm B, Wang T, Heimburger O, Bergstrom J. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol Dial Transplant 1998;13:S66–73.
  50. Ikizler T, Greene J, Wingard R, et al. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995;6:1386–91.
  51. Harty J, Boulton H, Faragher B, et al. The influence of small solute clearance on dietary protein intake in continuous ambulatory peritoneal dialysis patients: a methodologic analysis based on cross-sectional and prospective studies. Am J Kidney Dis 1996;28:553–601.
  52. Suda Y, Hiroshige K, Ohta T, et al. The contribution of residual renal function to overall nutritional status in chronic hemodialysis patients. Nephrol Dial Transplant 2000;15:396–401.
  53. Eggers DW. Mortality rates among dialysis patients in Medicare’s end-stage renal disease program. Am J Kidney Dis 1990;15:414–42.
  54. Bailey JL, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitinproteasome pathway. J Clin Invest 1996;97:1447–53.
  55. Moxley MA, Bell NH, Wagle SR, et al. Parathyroid hormone stimulation of glucose and urea production in isolated liver cells. Am J Physiol 1974;227:1058–61.
Received for publication April 16, 2002. Accepted for publication July 12, 2002.


作者: Angela Yee-Moon Wang
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具